Expression and interconversion of neuron-specific enolase in patient sera and extracts from small-cell lung cancer cells

Tumor Biology

Volumn 17, Issue 5, 1996, Pages 271-280

  Paus, Elisabeth ^a   Myklebust, Arne T ^a  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

Isoenzymes; Malignant melanoma; Neuron specific enolase; Small cell lung cancer cell lines; Enolase

Indexed keywords

ISOENZYME; MAGNESIUM; NEURON SPECIFIC ENOLASE;

ARTICLE; BLOOD LEVEL; CONTROLLED STUDY; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; LUNG SMALL CELL CANCER; MELANOMA; PRIORITY JOURNAL; TUMOR CELL LINE;

EID: 0029791931     PISSN: 10104283     EISSN: 14230380     Source Type: Journal    
DOI: 10.1159/000217989     Document Type: Article

References (35)

1. Schmechel DE, Brightman MW, Marangos PJ: Neurons switch from non-neuronal enolase to neuron-specific enolase during differentiation, Brain Res 1980;190:195-214.
2. Marangos PJ, Parma AM, Goodwin FK: Functional properties of neuronal and glial isoenzymes of brain enolase, J Neurochem I978;31:727-732.
3. Carney DN, Marangos PJ, Ihde DC, Bunn PAJ, Cohen MH, Minna JD, Gazdar AF: Serum neuron-specific enolase: A marker for disease extent and response to therapy of small-cell lung cancer, Lancet 1982;1:583-585.
4. Ariyoshi Y, Kato K, Ishiguro Y, Ota K, Sato T, Suchi T: Evaluation of serum neuron-specific enolase as a tumor marker for carcinoma of the lung, Gann 1983;74:219-225.
5. Splinter TA, Carney DN, Teeling M, Peake MD, Kho GS, Oosterom R, Cooper EM: Neuron-specific enolase can be used as the sole guide to treat small-cell lung cancer patients in common clinical practice, J Cancer Res Clin Oncol 1989;115:400-401.
6. Jorgensen LGM, Osterlind K, Hansen HH, Cooper EH: Serum neuron-specific enolase (S-NSE) in progressive small-cell lung cancer (SCLC), BrJ Cancer 1994:70:759-761.
7. Johnson PW, Joel SP, Love S, Butcher M, Pandian MR, Squires L, Wrigley PF, Slevin ML: Tumour markers for prediction of survival and monitoring of remission in small cell lung cancer, Br J Cancer 1993;67:760-766.
8. Cooper EH: Neuron-specific enolase, Int J Biol Markers 1994:9:205-210.
9. Viallard JL, Tiget F, Hartmann O, Lemerlc J, Demcocq F, Malpuech G, Dastugue B: Serum neuron-specific/nonncuronal enolase ratio in the diagnosis of neuroblastomas, Cancer 1988;62:2546-2553.
10. Zeltzer PM, Marangos PJ, Evans AE, Schneider SL: Scrum neuron-specific enolase in children with neuroblastoma, Relationship to stage and disease course, Cancer 1986;57:1230-1234.
11. Dhillon AP, Rode J, Leathern A: Neurone specific enolase: An aid to the diagnosis of melanoma and neuroblastoma, Histopathology 1982:6: 81-92.
12. Wibe E, Hannisdal E, Paus E, Aam-dal S: Neuron-specific enolase as a prognostic factor in metastatic malignant melanoma, Eur J Cancer 1992;28A: 1692-1695.
13. Haimoto H, Takahashi Y, Koshika-wa T, Nagura H, Kato K: Immuno-histochcmical localization of gam-ma-enolase in normal human tissues other than nervous and neuroendocrine tissues, Lab Invest 1985:52: 257-263.
14. Schmechel D, Marangos PJ, Brightman M: Neurone-specific enolase is a molecular marker for peripheral and central neuroendocrine cells, Nature 1978;276:834-836.
15. Marangos PJ, Schmechel D, Zis AP, Goodwin FK: The existence and neurobiological significance of neuronal and glial forms of the glycolytic enzyme enolase, Biol Psychiatry 1979:14:563-579.
16. Kato K, Ishiguro Y, Suzuki F, Ito A, Semba R: Distribution of nervous system-specific forms of enolase in peripheral tissues, Brain Res 1982: 237:441-448.
17. Skogscid IM, Nordby UK, Urdal P, Paus E, Lilleaas F: Increased serum creatine kinase BB and neuron specific enolase following head injury indicates brain damage, Acta Neu-rochir (Wien) 1992:115:106-111.
18. Maxwell GD, Whitehead MC, Connolly SM, Marangos PJ: Development of neuron-specific enolase im-munoreactivity in avian nervous tissue in vivo and in vitro, Brain Res 1982;255:401-418.
19. Carney DN, Gazdar AF, Bepler G, Guccion JG, Marangos PJ, Moody TW, Zwcig MH, Minna JD: Establishment and identification of small cell lung cancer cell lines having classic and variant features, Cancer Res 1985;45:2913-2923.
20. Gazdar AF, Carney DN, Nau MM, Minna JD: Characterization of variant subclasses of cell lines derived from small cell lung cancer having distinctive biochemical, morphological, and growth properties, Cancer Res 1985:45:2924-2930.
21. Marangos PJ, Gazdar AF, Carney DN: Neuron specific enolase in human small cell carcinoma cultures, Cancer Lett 1982;15:67-71.
22. Splinter TA, Verkoelen CF, Vlastuin M, Kok TC, Rijksen G, Ilaglid KG, Boomsma F, van-de-Gaast A: Distinction of two different classes of small-cell lung cancer cell lines by enzymatically inactive neuron-specific enolase, Br J Cancer 1992:66: 1065-1069.
23. Paus E, Nustad K: Imntunoradio-metric assay for alpha gamma-and gamma gamma-enolasc (neuron-specific enolase), with use of monoclonal antibodies and magnetizable polymer particles, Clin Chcm 1989; 35:2034-2038.
24. Pettengill OS, Sorenson GD, Wur-ster Hill DH, Curphcy TJ, Noll WW, Cate CC, Maurer LH: Isolation and growth characteristics of continuous cell lines from small-cell carcinoma of the lung, Cancer 1980: 45:906-918.
25. Pettengill OS, Sorenson GD: Tissue culture and in vitro characteristics; in Greco AF (ed): Small Cell Lung Cancer, Orlando, Grunc & Stratton, 1981. pp 51-77.
26. Myklebust AT, Beiskc K, Pharo A, Davies CD, Aamdal S, Fodstad O: Selection of anti-SCLC antibodies for diagnosis of bone marrow metastasis, Br J Cancer SuppI 1991; 14: 49-53.
27. Stahli C, Staehclin T, Miggiano V, Schmidt J, Haring P: High frequencies of antigen-specific hybridomas: Dependence on immunization parameters and prediction by spleen cell analysis, J Immunol Methods 1980;32:297-304.
28. Galfre G, Milslein C: Preparation of monoclonal antibodies: Strategies and procedures, Methods Enzymol 1981;73:3-46.
29. Paus E, Risberg T: Establishment and evaluation of a radioimmunoassay for neuron-specific enolase, A marker for small cell lung cancer, Tumor Biol 1989;10:23-30.
30. Rider CC, Taylor CB: Enolase isoenzymes in rat tissues, Electrophoretic, chromatographic, immunological and kinetic properties, Biochim Biophys Acta 1974:365: 285-300.
31. Schmechel DE: Gamma-suhunil of the glycolytic enzyme enolase: Nonspecific or neuron specific? Lab Invest 1985;52:239-242.
32. Smith PK, Krohn RI, Hermanson GT, Mallia AK, Gartner FH, Provenzano MD, Fujimoto EK, Gockc NM, Olson BJ, Klenk DC: Measurement of protein using bicinchoninic acid (erratum in Anal Biochem 1987:163:279), Anal Biochem 1985; 150:76-85.
33. Gazdar AF, Linnoila RI: The pathology of lung cancer-Changing concepts and newer diagnostic techniques, Semin Oncol 1988:15:215-225.
34. Body JJ, Paesntans M, Sculier JP, Dabouis G, Bureau G, Libert P, Ber-chier MC, Raymakers N, Klastersky J: Monoclonal immunoradiometric assay and polyclonal radioimmunoassay compared for measuring neuron-specific enolase in patients with lung cancer, Clin Chem 1992; 38:748-751.
35. Marangos PJ, Schmechel D, Parma AM, Clark RL, Goodwin FK: Measurement of neuron-specific (NSE) and non-neuronal (NNE) isoenzymes of enolase in rat, monkey and human nervous tissue, J Ncurochem 1979:33:319-329.